If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Carmela Pisano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

Ray-Coquard, I., Cibula, D., Mirza, M. R., Reuss, A., Ricci, C., Colombo, N., Koch, H., Goffin, F., González-Martin, A., Ottevanger, P. B., Baumann, K., Bjørge, L., Lesoin, A., Burges, A., Rosenberg, P., Gropp-Meier, M., Harrela, M., Harter, P., Frenel, J. S., Minarik, T. & 4 others, Pisano, C., Hasenburg, A., Merger, M. & du Bois, A., 2020, In : International Journal of Cancer.

Research output: Contribution to journalArticle

  • PARP inhibitors in endometrial cancer: Current status and perspectives

    Musacchio, L., Caruso, G., Pisano, C., Cecere, S. C., Di Napoli, M., Attademo, L., Tambaro, R., Russo, D., Califano, D., Palaia, I., Muzii, L., Panici, P. B. & Pignata, S., 2020, In : Cancer Management and Research. 12, p. 6123-6135 13 p.

    Research output: Contribution to journalReview article

    Open Access
  • Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

    Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Dec 2019, In : Gynecologic Oncology. 155, 3, p. 406-412 7 p.

    Research output: Contribution to journalArticle

  • Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

    Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Dec 2019, In : Gynecologic Oncology. 155, 3, p. 406-412 7 p.

    Research output: Contribution to journalArticle

  • Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial: Gynecologic Oncology

    Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., 2019, In : Gynecol. Oncol.. 155, 3, p. 406-412 7 p.

    Research output: Contribution to journalArticle